Skip to content

Author

Muneeb Khawar

We have 6 of 131 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Meta-analysis Open access Oct 2026

CagriSema versus Semaglutide 2.4 mg monotherapy for weight management in adults with overweight or obesity, with or without type 2 diabetes: a systematic review, meta-analysis, and trial sequential analysis

Introduction Semaglutide 2.4 mg is the reference pharmacotherapy for weight management, yet many patients do not reach ambitious weight-loss targets. CagriSema, a fixed-dose combination of cagrilintide and semaglutide, may offer additional benefit through complementary mechanisms. We quantified its incremental efficacy...

Zehra Khatoon Rasool, Rajvi K. Shah, Ansharah E. Zinnia Batool et al. · 0 citations
Open access Sep 2026

Preoperative SGLT2 Inhibitor Use and Outcomes After Major Cardiac Procedures: A Propensity Score-Matched Analysis of the TriNetX Network

Background/Objectives: Sodium–glucose cotransporter-2 (SGLT2) inhibitors improve cardiorenal outcomes in patients with diabetes, heart failure, and chronic kidney disease. Their association with perioperative outcomes after major cardiac procedures remains uncertain. Methods: In this retrospective cohort study using th...

Mirza Muhammad Hadeed Khawar, Faizan Ahmed, M. Elnashar et al. · 0 citations
Editorial Open access Aug 2026

The Promise of Blood-Based Biomarkers in Early Detection and Care of Alzheimer’s Disease

BBMs play a crucial role in combating Alzheimer’s disease and should be prioritized, it is essential for governments and health organizations to finance evaluations in varied demographics, establish coverage policies, and integrate BBMs into existing workflows.

Muneeb Khawar, Pugazhandhi Bakthavatchalam · 0 citations
Open access Jul 2026

Temporal Trends and Disparities in Liver Cell Carcinoma and Hepatic Failure Mortality in the United States: A 24-Year Analysis from CDC WONDER, 1999-2023

LCC- and HF-related mortality declined overall, with descriptive subgroup variation by sex, race/ethnicity, urbanization, and geography, and targeted screening, hepatitis management, and equitable healthcare access are needed to address these patterns.

S. Khan, Muneeb Khawar, Muhammad Haris Khan et al. · 0 citations
Review Open access Aug 2026

WATCHMAN and Amplatzer Amulet for left atrial appendage occlusion: a systematic review and meta-analysis

Watchman and Amulet demonstrate no significant difference in efficacy and safety for most LAAC outcomes, including stroke and major bleeding, however, WATCHMAN is associated with a significantly lower risk of pericardial effusion but a higher risk of device thrombosis.

Samir Shamieh, Barakat Alsaqqa, Armstrong Nicholas Kpachi et al. · 0 citations
Jul 2026

Secondary Atrial Fibrillation in Critically Ill Sepsis Patients: Evaluating the Role of Early Oral Anticoagulants in a Retrospective Multi-Center Study.

In sepsis-associated NOAF, early OAC initiation was associated with reduced short-term mortality and ischemic stroke without excess bleeding or thromboembolic risk and warrant cautious interpretation given the observational design.

A. Qadeer, Michele Fouad, Doaa Bayomi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.